ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,037.59
1.06%
US Tech 100
21,171.24
-0.13%
Dow Jones
43,325.80
0.07%
Brent Oil
72.89
-0.54%
Bitcoin
95,685.64
0.00%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Immunovia Ab (publ) (0G8X)

  7. Immunovia Ab (publ) (0G8X) News

0G8X

Immunovia Ab (publ) (0G8X)

Immunovia Ab (publ)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0G8X
DateTimeSourceHeadlineSymbolCompany
12/19/202410:06AMPR Newswire (US)End of the Year 2024 Letter from Immunovia CEO Jeff BorcherdingLSE:0G8XImmunovia Ab (publ)
01/04/202410:59AMPR Newswire (US)Immunovia announces financial calendar for financial year 2024LSE:0G8XImmunovia Ab (publ)
01/04/202410:58AMPR Newswire (US)Immunovia announces financial calendar for financial year 2024LSE:0G8XImmunovia Ab (publ)
11/21/20235:40AMPR Newswire (US)Bulletin from the extraordinary general meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
11/21/20235:38AMPR Newswire (US)Bulletin from the extraordinary general meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
11/09/20233:03AMPR Newswire (US)Immunovia Publishes Interim Report for January-September 2023LSE:0G8XImmunovia Ab (publ)
11/09/20232:59AMPR Newswire (US)Immunovia Publishes Interim Report for January-September 2023LSE:0G8XImmunovia Ab (publ)
11/07/202310:14AMPR Newswire (US)Immunovia successfully completes discovery phase of next-generation test developmentLSE:0G8XImmunovia Ab (publ)
11/07/202310:12AMPR Newswire (US)Immunovia successfully completes discovery phase of next-generation test developmentLSE:0G8XImmunovia Ab (publ)
11/02/20236:02AMPR Newswire (US)Invitation to Immunovia's Q3 presentationLSE:0G8XImmunovia Ab (publ)
11/02/20236:00AMPR Newswire (US)Invitation to Immunovia's Q3 presentationLSE:0G8XImmunovia Ab (publ)
10/27/20233:06AMPR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)LSE:0G8XImmunovia Ab (publ)
10/27/20233:03AMPR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)LSE:0G8XImmunovia Ab (publ)
10/03/20235:01AMPR Newswire (US)Nomination Committee appointed for Immunovia AB (Publ)LSE:0G8XImmunovia Ab (publ)
10/03/20234:56AMPR Newswire (US)Nomination Committee appointed for Immunovia AB (Publ)LSE:0G8XImmunovia Ab (publ)
08/30/20236:30AMPR Newswire (US)Immunovia Publishes Interim Report for January-June 2023LSE:0G8XImmunovia Ab (publ)
08/30/20232:56AMPR Newswire (US)Immunovia Publishes Interim Report for January-June 2023LSE:0G8XImmunovia Ab (publ)
08/23/20232:08PMPR Newswire (US)Invitation to Immunovia's Q2 presentationLSE:0G8XImmunovia Ab (publ)
08/23/20232:06PMPR Newswire (US)Invitation to Immunovia's Q2 presentationLSE:0G8XImmunovia Ab (publ)
07/19/202312:47PMPR Newswire (US)Immunovia announces updated financial calendarLSE:0G8XImmunovia Ab (publ)
07/12/20233:15AMPR Newswire (US)Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer DetectionLSE:0G8XImmunovia Ab (publ)
07/12/20233:12AMPR Newswire (US)Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer DetectionLSE:0G8XImmunovia Ab (publ)
06/09/20234:19AMPR Newswire (US)Chief Executive Officer, Jeff Borcherding, buys Immunovia sharesLSE:0G8XImmunovia Ab (publ)
06/09/20234:11AMPR Newswire (US)Chief Executive Officer, Jeff Borcherding, buys Immunovia sharesLSE:0G8XImmunovia Ab (publ)
05/31/20236:16AMPR Newswire (US)Change in number of shares and votes in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
05/31/20236:13AMPR Newswire (US)Change in number of shares and votes in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
05/26/20237:43AMPR Newswire (US)Bulletin from the Annual General Meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
05/26/20237:41AMPR Newswire (US)Bulletin from the Annual General Meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
05/23/20233:03AMPR Newswire (US)Immunovia Publishes Interim Report for January-March 2023LSE:0G8XImmunovia Ab (publ)
05/23/20233:00AMPR Newswire (US)Immunovia Publishes Interim Report for January-March 2023LSE:0G8XImmunovia Ab (publ)
 Showing the most relevant articles for your search:LSE:0G8X

Your Recent History

USOTC
PHIL
PHI (PK)
USOTC
ZHUD
Zhuding (PK)
USOTC
CRTG
Coretec (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
RDGL
Vivos (QB)
USOTC
TPTW
TPT Global Tech (CE)
AMEX
KULR
KULR Technology
NASDAQ
ILLR
Triller
USOTC
HIRU
Hiru (PK)
USOTC
RDAR
Raadr (PK)
USOTC
HLLK
Hallmark Venture (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
NYSE
IONQ
IonQ
USOTC
SPZI
Spooz (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads